기준가
$100.97
운용 규모
$912.9M
보수율
-
배당수익률
0.00%
베타
0.55
통화
USD
| YTD | 1개월 | 3개월 | 1년 | 3년 | 5년 |
|---|---|---|---|---|---|
| +19.01% | +8.92% | +16.95% | +51.64% | +21.50% | +11.80% |
| 순위 | 종목코드 | 종목명 | 비중 |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Co | 24.17% |
| 2 | JNJ | Johnson & Johnson | 20.28% |
| 3 | RPRX | Royalty Pharma PLC Class A | 5.22% |
| 4 | VTRS | Viatris Inc | 5.00% |
| 5 | MRK | Merck & Co Inc | 4.47% |
| 6 | PFE | Pfizer Inc | 4.19% |
| 7 | BMY | Bristol-Myers Squibb Co | 4.17% |
| 8 | JAZZ | Jazz Pharmaceuticals PLC | 3.84% |
| 9 | ELAN | Elanco Animal Health Inc | 3.16% |
| 10 | ZTS | Zoetis Inc Class A | 2.84% |
The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified.
설정일: 2006-05-01